Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shugan Wendan Tang is a Traditional Chinese Medicine (TCM) herbal decoction derived from the classical Wendan Tang formula, modified to include liver-soothing (Shugan) properties. It is primarily composed of herbs such as Pinellia, Bamboo shavings, Bitter orange, Tangerine peel, Poria, and Licorice, often supplemented with Bupleurum and Scutellaria. The formula is traditionally used to treat syndromes characterized by liver qi stagnation and phlegm-heat internal harassment. In modern clinical research, it is being evaluated for its potential to treat metabolic syndrome and H-type essential hypertension (hypertension accompanied by high homocysteine levels). The therapeutic approach focuses on regulating metabolic dysfunction, reducing inflammation, and lowering homocysteine levels to mitigate cardiovascular risk.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shugan Wendan Tang.